自由之门ios

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

自由之门ios

Upcoming

Monday August 3, 2020 at 8:00 AM EDT
Monjuvi (tafasitamab-cxix) FDA approval

Tuesday August 4, 2020 at 8:00 AM EDT
Q2 2020 Incyte Corporation Earnings Conference Call

自由之门ios

View All Events

手机网络加速器免费

Monday April 6, 2020 at 8:00 AM EDT
江苏一网吧为吸引学生上网安装翻墙软件被查处_央广网 - cnr.cn:2021-12-9 · 网络安监员反电信诈骗:3年几乎没睡过几次好觉,数万元被骗、假冒淘宝客服、接警地浙江湖州、受害人是新手卖家，几条线索摆在眼前。诈骗过程很 ...

View All Events

View All Releases

自由之门ios

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914
mbooth@incyte.com

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141
layala@incyte.com

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773
cchiou@incyte.com

自由之门ios

自由之门ios

自由之门ios

自由之门ios

Upcoming

自由之门ios

手机网络加速器免费

手机网络加速器免费

Press Releases

FRONT >> News > View All

自由之门ios

04. Sidebar Quicklinks

自由之门ios